Antibiotic Peripheral Neuropathy Lawsuits

If you have suffered from symptoms of antibiotic-related peripheral neuropathy, you may be entitled to compensation. If you or someone you know has developed this condition, contact a personal injury attorney to determine if you have a case. If you think that you may have a claim, you can find a personal injury attorney to help you with your case. Listed below are some of the most common antibiotics that can cause peripheral neuropathy.


A new class action lawsuit filed in California against Johnson & Johnson alleges the company is liable for the permanent nerve damage caused by the popular antibiotic Levaquin. It alleges the drug maker failed to provide adequate warnings to customers about the risks of taking the medication. Joanne P. claims she developed peripheral neuropathy after taking the drug. Her lawsuit is Case No. 1:16-cv-04867 in the U.S. District Court for the District of New Jersey.

An aortic aneurysm is one of the most common side effects of Levaquin. The underlying condition can be fatal, and many victims have filed Levaquin and antibiotic peripheral neuropathy lawsuits to seek compensation. Tendon damage is another potential complication of Levaquin. In addition to tendon damage, the drug has been linked to ruptures of the Achilles, biceps, hand, thumb, and rotator cuff.


A Cipro and antibiotic peripheral neuropathy lawsuit are currently being reviewed by attorneys at Saiontz & Kirk, P.A., a law firm in New York. This lawsuit has been filed against Bayer after the drug maker was notified of reports of peripheral neuropathy caused by the FQ antibiotic Cipro. The lawsuit alleges that Bayer and other drugmakers intentionally failed to warn the public of the risks of the drug.

Although the connection between Cipro and peripheral neuropathy has been known for decades, the drug manufacturer, Bayer, has been slow to issue warnings to the public. Initial reports of the drug’s nerve damage were published in the 1990s and 2000s, but Bayer has failed to do anything about it. The drug was approved to treat anthrax, a disease caused by inhalation. However, postal workers who took the drug alleged that it caused their nerves to be damaged.


An Oklahoma couple claims that Avelox is defective and the company that produces it has not adequately warned consumers of possible side effects. Their lawsuit against Merck & Co. alleges that Avelox causes peripheral neuropathy and has caused irreversible nerve damage. Plaintiffs are seeking financial compensation for their pain and suffering. Read on for more information about the lawsuit. This article provides information on the Avelox and antibiotic peripheral neuropathy lawsuit.

FDA warned doctors in August 2013 of the risk of peripheral neuropathy in people taking fluoroquinolone antibiotics, including Avelox. The risk of developing this problem may begin within a week of starting Avelox treatment. Despite prior warnings about Avelox and peripheral neuropathy, the companies did not adequately warn patients and the medical community about the possibility of permanent nerve damage. This decision resulted in potential Avelox and antibiotic peripheral neuropathy lawsuits.

Avelox lawsuits

If you have experienced peripheral neuropathy after taking Avelox, you may be eligible to file an Avelox lawsuit against the drug manufacturer. Merck & Co. and Bayer Healthcare are the companies responsible for the sale of Avelox, which can cause peripheral neuropathy, a lifelong neurological condition. The lawsuit is a result of the drug’s failure to adequately warn consumers about possible side effects. The plaintiff filed a lawsuit after her husband was prescribed Avelox in 2008. The plaintiff later developed a range of symptoms that were difficult to deal with, including a new diagnosis of peripheral neuropathy.

The FDA issued a drug safety communication in August 2013 explaining the possible side effects of Avelox. The communication warned that the drug may cause nerve damage, which may last months or even years. Prior warnings for Avelox indicated that nerve damage was rare and would resolve on its own after the drug was discontinued. The manufacturer’s decision to withhold information from patients led to a potential increase in Avelox lawsuits for peripheral neuropathy.


In late 2018, the FDA finally issued a warning against fluoroquinolones for causing permanent nerve damage. These antibiotics are associated with an increased risk of aneurysms and dissections. Damage to the aorta can lead to heart attacks, strokes, and organ failure. In extreme cases, these drugs can even lead to death. Until now, the FDA has not warned about this risk, but the lawsuit is growing quickly.

While the FDA noted that peripheral neuropathy caused by fluoroquinolone antibiotics was rare, the agency reviewed adverse event reports and found dozens of cases of this disease. While symptoms often manifest days or weeks after the antibiotic has been taken, they may continue for months or years. Regardless of the cause of your condition, you may be entitled to compensation. To learn if you qualify, you should contact a lawyer who specializes in pharmaceutical injury lawsuits.

Side effects of antibiotics

Several antibiotics have been associated with the development of peripheral neuropathy. These associations are based on limited case reports and animal studies, and their essential basis relies on a temporal association with the drugs and the resolution of symptoms after stopping the treatment. The following article will focus on the side effects associated with the most commonly used antibiotics and highlight the potential underlying pathophysiologic mechanisms. Antibiotics for peripheral neuropathy may increase the risk of infection, burns, and other complications.

In a recent study, researchers evaluated a database of 1.3 million adults who had received amoxicillin-clavulanate or fluoroquinolone antibiotics. They found that the current use of systemic fluoroquinolone antibiotics was associated with a 47 percent increased risk of peripheral neuropathy, with the risk increasing with cumulative exposure. Despite these risks, the study concluded that the current use of amoxicillin-clavulanate antibiotics did not significantly increase the risk of peripheral neuropathy.

Leave a Reply

Your email address will not be published. Required fields are marked *